Please login to the form below

Not currently logged in
Email:
Password:

Greenleaf Health appoints drug and biological products principal

Dr John Jenkins joins the FDA regulatory consulting firm

Washington, US-based Greenleaf Health has appointed Dr John Jenkins as principal for drug and biological products.

Dr Jenkins brings over 25 years of experience from the US Food and Drug Administration (FDA) to the regulatory consulting firm, and is set to oversee its clients' drug development programmes through regulatory submission and post-approval requirements.

Most recently, he served as director of the office of new drugs within the FDA's Center for Drug Evaluation and Research. He previously held several leadership positions at the regulatory body, including director of the office of drug evaluation and director of the division of pulmonary drug products.

Patrick Ronan, chief executive of Greenleaf Health, said: “No one is more qualified than John to provide our clients strategic and technical guidance on FDA's regulatory process for drug and biological product development.

“Our experts at Greenleaf, who have a combined total of more than 200 years of FDA experience, help our clients navigate complex regulatory challenges. John's knowledge and experience in this area are unrivaled, and he makes a great addition to our team.”

20th February 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics